All Policy articles
-
NewsAMI calls for marine microbes to be at the heart of Europe’s future ocean policy
Applied Microbiology International (AMI) has responded to the European Commission’s consultation on the proposed EU Ocean Act, highlighting the essential contribution of marine microorganisms to ocean health, climate regulation, biodiversity and the blue bioeconomy.
-
-
NewsGerontological Society of America supports new immunization guidance
The Gerontological Society of America (GSA) supports the 2026-27 respiratory season vaccine evidence review released by the Vaccine Integrity Project (VIP) in collaboration with the American Medical Association.
-
CareersTrusting in science: Vito Latorre reports back on Parliamentary Links Day
University of East Anglia PhD student Vito Latorre shares his experiences of representing Applied Microbiology International at the Parliamentary Links Day in Westminster earlier this summer.
-
NewsAMI to lead workshop at the World One Health Congress this weekend
Applied Microbiology International (AMI) will be taking part in the 9th World One Health Congress, which will be held in Lisbon from 4-7 September, bringing together more than 1.200 participants, featuring almost 600 scientific posters and hosting over 80 sessions.
-
CareersMember Q&A: Tanja’s pathway to policy-oriented papers
Head of Bioresources Unit of the AIT Austrian Institute of Technology Tanja Kostić, PhD, reveals how AMI membership has supported her professional development and career journey.
-
NewsCall for expertise: Help shape the future of biotechnology regulation in Europe
Microbiologists have a rare opportunity to help shape future European biotechnology regulation. Applied Microbiology International (AMI) is calling on members to contribute as the European Commission seeks expert input on a proposed new Biotech Act.
-
NewsAntivaccine legislation is rising rapidly in US states, driven primarily by GOP push
A new study revealed that Republican lawmakers were responsible for 86 per cent of antivaccine bills introduced across state legislatures after the onset of the COVID-19 pandemic, raising concerns about public health.
-
CareersThe APPG on D&I in STEM: a recap of the evidence session on AI & gendered harms
In 2026, the All-Party Parliamentary Group (APPG) on Diversity & Inclusion in Science, Technology, Engineering, and Maths (STEM) launched a new project exploring Artificial Intelligence Equity in STEM.
-
NewsShare your story: Neurodivergent STEM professionals invited to take part in video project
Applied Microbiology International (AMI) is inviting researchers, students and professionals across the STEM community to take part in a new video series exploring the experiences of neurodivergent people working in science, technology, engineering and mathematics.
-
OpinionBiopiracy in microbiology: Who owns nature’s resources?
A growing global debate over “biopiracy” is raising urgent questions for microbiologists, researchers, industry and policymakers alike — and Applied Microbiology International is calling on members to help shape the conversation. Biopiracy refers to the unauthorised or unethical use of biological materials — including seeds, plants, ...
-
CareersVoice of the Future: Inspiring conversations at the science-policy interface
Earlier this year, Suparna Mitra and Alan Koh took part in the Royal Society of Biology’s Voice of the Future event at Parliament, representing AMI. Here they reflect on the experience and what they took away from it.
-
NewsEstablishing a regulatory framework for phage therapy in China
A new study summarizes the current regulatory frameworks for phage therapy in Western countries and China, and proposes a pathway for establishing a regulatory framework that enables safe and effective clinical application of phage therapy in China.
-
NewsStudy quantifies the staggering economic toll of TB
Researchers have found that TB wipes out an estimated 0.8 per cent of the world’s total economic potential every year. Losses are concentrated overwhelmingly in low- and middle-income countries, especially in South Asia and sub-Saharan Africa.
-
NewsAlgal bloom crisis shows climate risks need evaluative governance
Identifying and analysing climate risks is a necessary function of governments, but researchers argue such processes will not lead to effective action without taking additional steps to understand which risks are considered unacceptable by the community and prioritising responses accordingly.
-
NewsTen years on, the Nagoya Protocol on sharing genetic resources is still confusing scientists - so here’s some much-needed guidance
More than a decade after the Nagoya Protocol, which aims to fairly share the benefits of utilizing genetic resources, became law, scientists still face practical challenges and confusion. A new guide provides universally applicable frameworks for anyone working with biological resources.
-
CareersFrom one bench to another: Representing early-career scientists at Parliament’s Voice of the Future
Tyler Myers, an MPhil Candidate at the University of Cambridge, reports back from the Royal Society of Biology’s Voice of the Future event at Parliament, where he served as a guest panelist representing Applied Microbiology International.
-
NewsGlobal strategy to combat drug‑resistant fungi is about to change
An increasing number of fungi are becoming resistant to medication, posing serious risks for patients with weakened immune systems. That is why fifty researchers from around the world are calling for action against drug‑resistant fungi.
-
NewsCall for evidence: Why has the promise of personalised medicine failed to materialise on the ground?
A new inquiry by the UK Parliament’s Science and Technology Committee investigates why the NHS adoption of the UK’s cutting-edge life sciences innovations often fails - and what could be done to fix it. Members of AMI could be just the people to provide answers.
-
NewsWhy is vaccination for target populations plummeting in the UK? Share your insights!
As a group of leading UK health experts launches a new Commission on Access to Vaccines to understand why access levels are falling across the UK, Applied Microbiology International is calling on members to share their insights on childhood vaccinations.